Understanding the molecular basis of age-related macular degeneration and how the identification of new mechanisms may aid the development of novel therapies

References

• Coleman HR, Chan CC, Ferris FL III, Chew EY. Age-related macular degeneration. Lancet372, 1835–1845 (2008).
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB et al.; The International ARM Epidemiology Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol.39(5), 367–374 (1995).
   PubMed Web of Science ®Google Scholar
• Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE–Bruch’s membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res.20, 705–732 (2001).
   PubMed Web of Science ®Google Scholar
• Anderson DH, Radeke MJ, Gallo NB et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res.29(2), 95–112 (2010).
   PubMed Web of Science ®Google Scholar
• Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science308, 421–424 (2005).
   PubMed Web of Science ®Google Scholar
• Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science308, 385–389 (2005).
   PubMed Web of Science ®Google Scholar
• Haines JL, Hauser MA, Schmidt S et al. Complement factor H increases the risk of age-related macular degeneration. Science308, 419–421 (2005).
   PubMed Web of Science ®Google Scholar
• Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA102, 7227–7232 (2005).
   PubMed Web of Science ®Google Scholar
• Hecker LA, Edwards AO, Ryu E et al. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum. Mol. Genet.19, 209–215 (2010).
   PubMed Web of Science ®Google Scholar
• Day AJ, Willis AC, Ripoche J, Sim RB. Sequence polymorphism of human complement factor H. Immunogenetics27, 211–214 (1988).
   PubMed Web of Science ®Google Scholar
• DeCórdoba SR, Rubinstein P. Genetic polymorphism of human factor H (β1H). J. Immunol.132, 1906–1908 (1984).
   PubMed Web of Science ®Google Scholar
• Hageman GS, Hancox LS, Taiber AJ et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes that protect against age-related macular degeneration: identification, ethnic distribution and evolutionary implications. Ann. Med.38, 592–604 (2006).
   PubMed Web of Science ®Google Scholar
• Nonyane BAS, Nitsch D, Whittaker JC et al. An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Ophthalmol. Vis. Sci.51, 2393–2402 (2010).
   PubMed Web of Science ®Google Scholar
• Tortajada A, Montes T, Martínez-Barricarte R et al. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum. Mol. Genet.18, 3452–3461 (2009).
   PubMed Web of Science ®Google Scholar
• Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet.38, 1173–1177 (2006).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S, Ripke S, Li M et al. Associations of CHFR1–CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat. Genet.42, 553–555 (2010).
   PubMed Web of Science ®Google Scholar
• Clark SJ, Higman VA, Mulloy B et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J. Biol. Chem.281, 24713–24720 (2006).
   PubMed Web of Science ®Google Scholar
• Sjöberg AP, Trouw LA, Clark SJ et al. The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA and necrotic cells. J. Biol. Chem.282, 10894–10900 (2007).
   PubMed Web of Science ®Google Scholar
• Prosser BE, Johnson S, Roversi P et al. Structural basis for complement factor H-linked age-related macular degeneration. J. Exp. Med.204, 2277–2283 (2007).
   PubMed Web of Science ®Google Scholar
• Laine M, Jarva H, Seitsonen S et al. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J. Immunol.178, 3831–3836 (2007).
   PubMed Web of Science ®Google Scholar
• Skerka C, Lauer N, Weinberger AA et al. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol. Immunol.44, 3398–3406 (2007).
   PubMed Web of Science ®Google Scholar
• Yu J, Wiita P, Kawaguchi R et al. Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry46, 8451–8461 (2007).
   PubMed Web of Science ®Google Scholar
• Ormsby RJ, Ranganathan S, Tong JC et al. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.49, 1763–1770 (2008).
   PubMed Web of Science ®Google Scholar
• Herbert AP, Deakin JA, Schmidt CQ et al. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J. Biol. Chem.282, 18960–18968 (2007).
   PubMed Web of Science ®Google Scholar
• Sjöberg AP, Manderson GA, Mörgelin M, Day AJ, Heinegård D, Blom AM. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol. Immunol.46, 830–839 (2009).
   PubMed Web of Science ®Google Scholar
• Clark SJ, Perveen R, Hakobyan S et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch’s membrane in human retina. J. Biol. Chem.285, 30192–30202 (2010).
   PubMed Web of Science ®Google Scholar
• Haapasalo K, Jarva H, Siljander T, Tewodros W, Vuopio-Varkila J, Jokiranta TS. Complement factor H allotype 402H is associated with increased C3b opsonisation and phagocytosis of Streptococcus pyogenes. Mol. Microbiol.70, 583–594 (2008).
   PubMed Web of Science ®Google Scholar
• Orth D, Khan AB, Naim A et al. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in haemolytic uremic syndrome. J. Immunol.182, 6394–6400 (2009).
   PubMed Web of Science ®Google Scholar
• Clark SJ, Bishop PN, Day AJ. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem. Soc. Trans.38, 1342–1348 (2010).
   PubMed Web of Science ®Google Scholar
• Ripoche J, Day AJ, Harris TJ, Sim RB. The complete amino acid sequence of human complement factor H. Biochem. J.249, 593–602 (1988).
   PubMed Web of Science ®Google Scholar
• Schneider MC, Prosser BE, Caesar JJ et al. Neisseria meningitides recruits factor H using protein mimicry of host carbohydrates. Nature458, 890–893 (2009).
   PubMed Web of Science ®Google Scholar
• Kelly U, Yu L, Kumar P et al. Heparan sulphate, including that in Bruch’s membrane, inhibits the complement alternative pathway: implications for age-related macula degeneration. J. Immunol.185, 5486–5494 (2010).
   PubMed Web of Science ®Google Scholar
• Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparin sulphate. Annu. Rev. Biochem.71, 435–471 (2002).
   PubMed Web of Science ®Google Scholar
• Avery RL. The plague and macular degeneration. Ophthalmology117, 2442 (2010).
   PubMedGoogle Scholar
• Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl Acad. Sci. USA103, 17456–17461 (2006).
   PubMed Web of Science ®Google Scholar
• Yuan X, Gu X, Crabb JS et al. Quantitative proteomics: comparison of the macular Bruch’s membrane/choroid complex from age-related macular degeneration and normal eyes. Mol. Cell Proteomics9, 1031–1046 (2010).
   PubMed Web of Science ®Google Scholar
• Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA. The dynamic nature of Bruch’s membrane. Prog. Retin. Eye Res.29, 1–18 (2010).
   PubMed Web of Science ®Google Scholar
• Zipfel PF, Skerka C, Hellwage J et al. Structure-function studies of the complement system. Biochem. Soc. Trans.30, 971–978 (2002).
   PubMed Web of Science ®Google Scholar
• Lyzogubov VV, Tytarenko RG, Jha P, Liu J, Bora NS, Bors PS. Role of ocular complement factor H in a murine model of choroidal neovascularization. Am. J. Pathol.177, 1870–1880 (2010).
   PubMed Web of Science ®Google Scholar
• Ramkumar HL, Zhang J, Chan CC. Retinal unltrastructure of murine models of dry age-related macular degeneration (AMD). Prog. Retin. Eye Res.29, 169–190 (2010).
   PubMed Web of Science ®Google Scholar
• Coffey PJ, Gias C, McDermott CJ et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc. Natl Acad. Sci. USA104, 16651–16656 (2007).
   PubMed Web of Science ®Google Scholar
• Ufret-Vincenty RL, Aredo B, Liu X et al. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. Invest. Ophthalmol. Vis. Sci.51, 5878–5887 (2010).
   PubMed Web of Science ®Google Scholar
• Hollyfield JG, Raybron ME, Midura RJ, Shadrach KG, Acharya S. Chondroitin sulphate proteoglycan core proteins in the interphotoreceptor matrix: a comparative study using biochemical and immunohistochemical analysis. Exp. Eye Res.69, 311–322 (1999).
   PubMed Web of Science ®Google Scholar